Investigational Drug Information for Foliglurax
✉ Email this page to a colleague
What is the drug development status for Foliglurax?
Foliglurax is an investigational drug.
There have been 6 clinical trials for Foliglurax.
The most recent clinical trial was a Phase 2 trial, which was initiated on January 15th 2018.
The most common disease conditions in clinical trials are Parkinson Disease, Dyskinesias, and [disabled in preview]. The leading clinical trial sponsors are H. Lundbeck A/S, Prexton Therapeutics, and [disabled in preview].
Summary for Foliglurax
| US Patents | 0 |
| International Patents | 64 |
| US Patent Applications | 10 |
| WIPO Patent Applications | 3 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2018-01-15) |
| Vendors | 9 |
Recent Clinical Trials for Foliglurax
| Title | Sponsor | Phase |
|---|---|---|
| Effects of Repeated Doses of Foliglurax on Drug Metabolizing Enzymes in Healthy Subjects | H. Lundbeck A/S | Phase 1 |
| Study Investigating Effects of Foliglurax in Patients With Parkinson's Disease (PD) and Healthy Subjects | H. Lundbeck A/S | Phase 1 |
| Binding of Foliglurax to Regions in the Brain in Healthy Participants and in Patients With Parkinson's Disease (PD) | H. Lundbeck A/S | Phase 1 |
Clinical Trial Summary for Foliglurax
Top disease conditions for Foliglurax
Top clinical trial sponsors for Foliglurax
US Patents for Foliglurax
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Foliglurax
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Foliglurax | Australia | AU2015308438 | 2034-08-27 | ⤷ Try a Trial |
| Foliglurax | Australia | AU2016313138 | 2034-08-27 | ⤷ Try a Trial |
| Foliglurax | Canada | CA2956191 | 2034-08-27 | ⤷ Try a Trial |
| Foliglurax | Canada | CA2995313 | 2034-08-27 | ⤷ Try a Trial |
| Foliglurax | Chile | CL2018000497 | 2034-08-27 | ⤷ Try a Trial |
| Foliglurax | China | CN106715444 | 2034-08-27 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
